A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
University of Pittsburgh
Incyte Corporation
Incyte Corporation
Children's National Research Institute
Xencor, Inc.
Incyte Corporation